Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis

Schizophrenia Bulletin

Volumn 40, Issue 1, 2014, Pages 50-59

  Moberg, Paul J ^a,b   Kamath, Vidyulata ^a,b   Marchetto, Dana M ^a   Calkins, Monica E ^a   Doty, Richard L ^b   Hahn, Chang Gyu ^a   Borgmann Winter, Karin E ^a   Kohler, Christian G ^a   Gur, Raquel E ^a   Turetsky, Bruce I ^a,b  

^a Department of Psychiatry   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

olfaction; psychosis; schizophrenia prodrome; schizotypy; smell

Indexed keywords

CHLORPROMAZINE;

AGE; ARTICLE; DISEASE DURATION; EDUCATIONAL STATUS; FIRST DEGREE RELATIVE; HANDEDNESS; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; META ANALYSIS; OLFACTORY DISCRIMINATION; ONSET AGE; PRIORITY JOURNAL; PSYCHOSIS; PUBLISHING; SCHIZOPHRENIA; SCHIZOTYPY; SEX; SMELLING; SMOKING;

OLFACTION; PSYCHOSIS; SCHIZOPHRENIA PRODROME; SCHIZOTYPY; SMELL;

GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; OLFACTION DISORDERS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER;

EID: 84892653190     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbt049     Document Type: Article

References (55)

1. Moberg PJ, Agrin R, Gur RE, Gur RC, Turetsky BI, Doty RL. Olfactory dysfunction in schizophrenia: a qualitative and quantitative review. Neuropsychopharmacology. 1999;21:325-340.
2. Brewer WJ, Pantelis C, Anderson V, et al. Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis. Am J Psychiatry. 2001;158:107-115.
3. Moberg PJ, Doty RL, Turetsky BI, et al. Olfactory identification deficits in schizophrenia: correlation with duration of illness. Am J Psychiatry. 1997;154:1016-1018.
4. Rupp CI, Fleischhacker WW, Kemmler G, et al. Various bilateral olfactory deficits in male patients with schizophrenia. Schizophr Bull. 2005;31:155-165.
5. Wu J, Buchsbaum MS, Moy K, et al. Olfactory memory in unmedicated schizophrenics. Schizophr Res. 1993;9:41-47.
6. Doop ML, Park S. On knowing and judging smells: identification and hedonic judgment of odors in schizophrenia. Schizophr Res. 2006;81:317-319.
7. Moberg PJ, Arnold SE, Doty RL, et al. Impairment of odor hedonics in men with schizophrenia. Am J Psychiatry. 2003;160:1784-1789.
8. Plailly J, d'Amato T, Saoud M, Royet JP. Left temporo-limbic and orbital dysfunction in schizophrenia during odor familiarity and hedonicity judgments. Neuroimage. 2006;29:302-313.
9. Turetsky BI, Moberg PJ, Yousem DM, Doty RL, Arnold SE, Gur RE. Reduced olfactory bulb volume in patients with schizophrenia. Am J Psychiatry. 2000;157:828-830.
10. Turetsky BI, Moberg PJ, Roalf DR, Arnold SE, Gur RE. Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia. Arch Gen Psychiatry. 2003;60:1193-1200.
11. Rupp CI, Fleischhacker WW, Kemmler G, et al. Olfactory functions and volumetric measures of orbitofrontal and limbic regions in schizophrenia. Schizophr Res. 2005;74:149-161.
12. Turetsky BI, Hahn CG, Arnold SE, Moberg PJ. Olfactory receptor neuron dysfunction in schizophrenia. Neuropsychopharmacology. 2009;34:767-774.
13. Turetsky BI, Moberg PJ, Owzar K, Johnson SC, Doty RL, Gur RE. Physiologic impairment of olfactory stimulus processing in schizophrenia. Biol Psychiatry. 2003;53:403-411.
14. Kamath V, Turetsky BI, Calkins ME, et al. Olfactory processing in schizophrenia, non-ill first-degree family members, and young people at risk for psychosis. World J Biol Psychiatry. 2012. In press.
15. Woodberry KA, Seidman LJ, Giuliano AJ, Verdi MB, Cook WL, McFarlane WR. Neuropsychological profiles in individuals at clinical high risk for psychosis: relationship to psychosis and intelligence. Schizophr Res. 2010;123:188-198.
16. Brewer WJ, Wood SJ, McGorry PD, et al. Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am J Psychiatry. 2003;160:1790-1794.
17. Cohen AS, Brown LA, Auster TL. Olfaction, "olfiction," and the schizophrenia-spectrum: an updated meta-analysis on identification and acuity. Schizophr Res. 2012;135:152-157.
18. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
19. Compton MT, McKenzie Mack L, Esterberg ML, et al. Associations between olfactory identification and verbal memory in patients with schizophrenia, first-degree relatives, and non-psychiatric controls. Schizophr Res. 2006;86:154-166.
20. McLean D, F?on F, Mackay-Sim A, et al. Paradoxical association between smoking and olfactory identification in psychosis versus controls. Aust N Z J Psychiatry. 2004;38:81-83.
21. Kopala LC, Good KP, Morrison K, Bassett AS, Alda M, Honer WG. Impaired olfactory identification in relatives of patients with familial schizophrenia. Am J Psychiatry. 2001;158:1286-1290.
22. Good KP, Leslie RA, McGlone J, Milliken HI, Kopala LC. Sex differences in olfactory function in young patients with psychotic disorders. Schizophr Res. 2007;97:97-102.
23. Andreasen NC. Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, IA: University of Iowa; 1984.
24. Andreasen NC. Scale for the Assessment of Negative Symptoms (SANS). Iowa City, IA: University of Iowa; 1984.
25. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
26. Comprehensive Meta-Analysis [computer program]. Version. Englewood, NJ: Biostat; 2005.
27. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. New York: Lawrence Erlbaum Associates; 1988.
28. Hedges L, Olkin I. Statistical Methods for Meta-Analysis. New York: Academic Press; 1985.
29. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101.
30. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
31. Kamath V, Turetsky BI, Calkins ME, et al. The influence of valence and intensity on odor identification ability in schizophrenia patients, their nonpsychotic first-degree relatives, and youths at-risk for psychosis. Unpublished manuscript.
32. Good KP, Martzke JS, Milliken HI, Honer WG, Kopala LC. Unirhinal olfactory identification deficits in young male patients with schizophrenia and related disorders: association with impaired memory function. Schizophr Res. 2002;56:211-223.
33. Doty RL, McKeown DA, Lee WW, Shaman P. A study of the test-retest reliability of ten olfactory tests. Chem Senses. 1995;20:645-656.
34. Cain WS. Bilateral interaction in olfaction. Nature. 1977;268: 50-52.
35. Doty RL, Bromley SM, Moberg PJ, Hummel T. Laterality in human nasal chemoreception. In: Christman S, ed. Cerebral Asymmetries in Sensory and Perceptual Processing. Amsterdam: North Holland Publishing; 1991:497-542.
36. Bromley SM, Doty RL. Odor recognition memory is better under bilateral than unilateral test conditions. Cortex. 1995;31:25-40.
37. David AS. Tachistoscopic tests of colour naming and matching in schizophrenia: evidence for posterior callosum dysfunction? Psychol Med. 1987;17:621-630.
38. Carr SA. Interhemispheric transfer of stereognostic information in chronic schizophrenics. Br J Psychiatry. 1980;136:53-58.
39. Green P, Kotenko V. Superior speech comprehension in schizophrenics under monaural versus binaural listening conditions. J Abnorm Psychol. 1980;89:399-408.
40. Hallett S, Green P. Possible defects of interhemispheric integration in children of schizophrenics. J Nerv Ment Dis. 1983;171:421-425.
41. Ugur T, Weisbrod M, Franzek E, Pf?ler U, Sauer H. Olfactory impairment in monozygotic twins discordant for schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2005;255:94-98.
42. Moberg PJ, Arnold SE, Doty RL, et al. Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological, and volumetric MRI measures. J Clin Exp Neuropsychol. 2006;28:1444-1461.
43. Brewer WJ, Pantelis C, Anderson V, et al. Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis. Am J Psychiatry. 2001;158:107-115.
44. Malaspina D, Coleman E, Goetz RR, et al. Odor identification, eye tracking and deficit syndrome schizophrenia. Biol Psychiatry. 2002;51:809-815.
45. Sirota P, Davidson B, Mosheva T, Benhatov R, Zohar J, Gross-Isseroff R. Increased olfactory sensitivity in first episode psychosis and the effect of neuroleptic treatment on olfactory sensitivity in schizophrenia. Psychiatry Res. 1999;86:143-153.
46. Kamath V, Moberg PJ, Gur RE, Doty RL, Turetsky BI. Effects of the val(158)met catechol-O-methyltransferase gene polymorphism on olfactory processing in schizophrenia. Behav Neurosci. 2012;126:209-215.
47. Doty RL, Risser JM. Influence of the D-2 dopamine receptor agonist quinpirole on the odor detection performance of rats before and after spiperone administration. Psychopharmacology (Berl). 1989;98:310-315.
48. Frye RE, Schwartz BS, Doty RL. Dose-related effects of cigarette smoking on olfactory function. JAMA. 1990;263: 1233-1236.
49. Martzke JS, Kopala LC, Good KP. Olfactory dysfunction in neuropsychiatric disorders: review and methodological considerations. Biol Psychiatry. 1997;42:721-732.
50. Jacobsen LK, D'Souza DC, Mencl WE, Pugh KR, Skudlarski P, Krystal JH. Nicotine effects on brain function and functional connectivity in schizophrenia. Biol Psychiatry. 2004;55:850-858.
51. Smith RC, Warner-Cohen J, Matute M, et al. Effects of nicotine nasal spray on cognitive function in schizophrenia. Neuropsychopharmacology. 2006;31:637-643.
52. Smith RC, Singh A, Infante M, Khandat A, Kloos A. Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology. 2002;27:479-497.
53. Giuliano AJ, Li H, Mesholam-Gately RI, Sorenson SM, Woodberry KA, Seidman LJ. Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review. Curr Pharm Des. 2012;18:399-415.
54. Turetsky BI, Kamath V, Calkins ME, et al. Olfaction and schizophrenia clinical risk status: just the facts. Schizophr Res. 2012;139:260-1.
55. Nguyen-Khoa BA, Goehring EL Jr, Vendiola RM, Pezzullo JC, Jones JK. Epidemiologic study of smell disturbance in 2 medical insurance claims populations. Arch Otolaryngol Head Neck Surg. 2007;133:748-757.